AKT1 is an important regulator of the tumorigenic processes, migration, spreading, therapeutic sensitivity, resistance, survival, and proliferation of LC cells, and is a promising theragnostic target [64–67]. This evidence concerns the gene AKT1 and laryngotracheoesophageal cleft.